| scholarly article | Q13442814 |
| P50 | author | Shehzad Basaria | Q44358165 |
| P2093 | author name string | Grace Huang | |
| P2860 | cites work | Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government | Q28243288 |
| Anabolic steroid use and perceived effects in ten weight-trained women athletes | Q28308008 | ||
| A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents | Q28378401 | ||
| Intersex and the Olympic Games | Q29030469 | ||
| Functional Voice Testing Detects Early Changes in Vocal Pitch in Women During Testosterone Administration. | Q30382392 | ||
| Chronic exposure to anabolic androgenic steroids alters activity and synaptic function in neuroendocrine control regions of the female mouse | Q30425290 | ||
| Androgen supplementation in older women: too much hype, not enough data | Q30702926 | ||
| Sexual difference in bone geometry of adult patients with classical congenital adrenal hyperplasia: data using peripheral quantitative computed tomography | Q30846551 | ||
| Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study | Q33891351 | ||
| Gender verification of female athletes | Q33938379 | ||
| Effects of androgenic-anabolic steroids in athletes | Q33979780 | ||
| Adverse effects of anabolic steroids in athletes. A constant threat | Q33988494 | ||
| Gender verification of female Olympic athletes | Q34153606 | ||
| Prenatal endocrine influences on sexual orientation and on sexually differentiated childhood behavior | Q34165595 | ||
| Endocrine profiles in 693 elite athletes in the postcompetition setting | Q34408202 | ||
| Androgen levels in adult females: changes with age, menopause, and oophorectomy. | Q34411038 | ||
| Behavioural manifestations of anabolic steroid use. | Q34429602 | ||
| MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions | Q34468501 | ||
| Testosterone and sport: current perspectives | Q35690905 | ||
| Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia | Q36061768 | ||
| Congenital Adrenal Hyperplasia in an Elite Female Soccer Player; What Sports Medicine Clinicians Should Know about This? | Q36243371 | ||
| Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial | Q36430047 | ||
| The new policy on hyperandrogenism in elite female athletes is not about "sex testing" | Q36561801 | ||
| Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women | Q36598093 | ||
| Androgenic-anabolic steroids and the Olympic Games | Q37127303 | ||
| The relation between athletic sports and prevalence of amenorrhea and oligomenorrhea in Iranian female athletes | Q37320453 | ||
| The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates | Q37653046 | ||
| Endogenous hyperandrogenism and exercise capacity lessons from the exercise-congenital adrenal hyperplasia model. | Q37895661 | ||
| Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. | Q38587545 | ||
| Serum androgen profile and physical performance in women Olympic athletes | Q38711263 | ||
| Ethics of Regulating Competition for Women with Hyperandrogenism | Q38718749 | ||
| Androgens and athletic performance of elite female athletes | Q39149614 | ||
| Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women | Q39408485 | ||
| Anabolic steroids in athletics: How well do they work and how dangerous are they? | Q40171830 | ||
| Artificial illness as a result of non-medical use of anabolic androgenic steroids: A case report and a review of literature | Q40549674 | ||
| The climacteric ovary as a functional gonadotropin-driven androgen-producing gland | Q40657866 | ||
| Endocrine aspects of anabolic steroids | Q41525238 | ||
| Hyperandrogenism among Elite Adolescent Female Athletes | Q42820036 | ||
| Body composition and metabolic profile in women with complete androgen insensitivity syndrome | Q43276832 | ||
| Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance | Q44442555 | ||
| Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study | Q44865352 | ||
| Muscle strength in girls with congenital adrenal hyperplasia | Q44952308 | ||
| Effects of testosterone replacement in human immunodeficiency virus-infected women with weight loss. | Q45197385 | ||
| The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women | Q45756789 | ||
| Medical and ethical concerns regarding women with hyperandrogenism and elite sport. | Q46090546 | ||
| Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine | Q46182317 | ||
| Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study | Q46299275 | ||
| Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study | Q46945023 | ||
| Hormonal Eligibility Criteria for 'Includes Females' Competition: A Practical but Problematic Solution | Q48867887 | ||
| Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism. | Q50856918 | ||
| Serum androgen levels in elite female athletes. | Q51119456 | ||
| Hyperandrogenism may explain reproductive dysfunction in olympic athletes. | Q51637109 | ||
| Determinants of serum total and free testosterone levels in women over the age of 65 years. | Q51929313 | ||
| Hyperandrogenism and intersex controversies in women's olympics. | Q53123526 | ||
| Congenital adrenal hyperplasia | Q56483508 | ||
| Histologic and histochemical study of effects of anabolic steroids on the female larynx | Q69195035 | ||
| Serum Androstenedione and Testosterone Levels During the Menstrual Cycle | Q69475748 | ||
| Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer | Q69741087 | ||
| Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin | Q70048283 | ||
| Endocrine activity of the postmenopausal ovary: the effects of pituitary down-regulation and oophorectomy | Q71869615 | ||
| Voice Change in Adult Women Caused by Virilizing Agents | Q72218583 | ||
| Steroid production and responsiveness to gonadotropin in isolated stromal tissue of human postmenopausal ovaries | Q72848262 | ||
| Serum androgen levels and muscle mass in women with polycystic ovary syndrome | Q78206272 | ||
| Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition | Q86070715 | ||
| P304 | page(s) | 56-64 | |
| P577 | publication date | 2017-07-12 | |
| P1433 | published in | Molecular and Cellular Endocrinology | Q1573600 |
| P1476 | title | Do anabolic-androgenic steroids have performance-enhancing effects in female athletes? | |
| P478 | volume | 464 |
| Q93387272 | Annual banned-substance review: Analytical approaches in human sports drug testing | cites work | P2860 |
Search more.